BrainStorm Cell Therapeutics
BCLI
#10401
Rank
A$9.97 M
Marketcap
A$0.90
Share price
0.00%
Change (1 day)
-63.40%
Change (1 year)

Earnings for BrainStorm Cell Therapeutics (BCLI)

Earnings in 2025 (TTM): -A$17.7 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$17.51 Million, an increase over its 2023 earnings that were of -A$25.89 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BrainStorm Cell Therapeutics from 2003 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$17.7 Million1.11%
2024 -A$17.51 Million-32.39%
2023 -A$25.89 Million-29.18%
2022 -A$36.56 Million-0.74%
2021 -A$36.83 Million-23.12%
2020 -A$47.91 Million36.8%
2019 -A$35.02 Million66.71%
2018 -A$21.01 Million181.66%
2017 -A$7.46 Million-0.6%
2016 -A$7.51 Million-41.31%
2015 -A$12.79 Million-8.22%
2014 -A$13.93 Million89.74%
2013 -A$7.34 Million42.27%
2012 -A$5.16 Million-12.45%
2011 -A$5.9 Million63.04%
2010 -A$3.62 Million35.52%
2009 -A$2.67 Million-48.99%
2008 -A$5.23 Million-44.39%
2007 -A$9.41 Million
2005 -A$4.87 Million-91.44%
2004 -A$56.9 Million94007.62%
2003 -A$0.07 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
A$14.88 B-86,455.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-A$1.14 Billion 6,468.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-A$1.2 Billion 6,805.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$2.86 B-16,731.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
A$31.11 M-280.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
-A$0.39 Billion 2,131.73%๐Ÿ‡บ๐Ÿ‡ธ USA